Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527585) titled 'Study on Biomarkers of Immune-Related Adverse Events' on April 7.
Study Type: Observational
Primary Sponsor: Huazhong University of Science and Technology
Condition:
Immune-Related Adverse Events
Recruitment Status: Not recruiting
Date of First Enrollment: April 2026
Target Sample Size: 440
To know more, visit https://clinicaltrials.gov/study/NCT07527585
Disclaimer: Curated by HT Syndication....